Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,570 | 2,930 | 7,200 | 11,181 | N/A |
| Receivables | 144 | 375 | 851 | 712 | N/A |
| TOTAL | $14,714 | $3,305 | $8,051 | $11,893 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 11,773 | 12,319 | 11,592 | 10,658 | N/A |
| Other Non-Current Assets | 1,924 | 2,077 | 2,129 | 2,179 | 0 |
| TOTAL | $13,697 | $14,396 | $13,721 | $12,837 | $N/A |
| Total Assets | $28,411 | $17,701 | $21,772 | $24,730 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18,700 | 18,793 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,117 | 969 | 3,052 | 1,640 | 0 |
| TOTAL | $20,009 | $19,965 | $3,242 | $1,835 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 17,217 | 35,211 | N/A |
| Other Non-Current Liabilities | 2,162 | 2,276 | 1,848 | 5,549 | 0 |
| TOTAL | $2,162 | $2,276 | $19,065 | $40,760 | $N/A |
| Total Liabilities | $22,171 | $22,241 | $22,307 | $42,595 | $N/A |
| Shareholders' Equity | |||||
| Retained earnings | -99,874 | -101,024 | -90,292 | -105,600 | N/A |
| TOTAL | $6,240 | $-4,540 | $-535 | $-17,865 | $N/A |
| Total Liabilities And Equity | $28,411 | $17,701 | $21,772 | $24,730 | $0 |